GlycoNex Incorporation (TPEX:4168)
Taiwan · Delayed Price · Currency is TWD 22.50
-0.35 (-1.53%)
May 8, 2026, 1:30 PM CST
GlycoNex Incorporation Market Cap
GlycoNex Incorporation has a market cap or net worth of 2.43 billion as of May 8, 2026. Its market cap has increased by 33.14% in one year.
Market Cap
2.43B
Enterprise Value
2.21B
Revenue
37.86M
Ranking
n/a
PE Ratio
n/a
Stock Price
22.50
Market Cap Chart
Since December 16, 2011, GlycoNex Incorporation's market cap has increased from 1.51B to 2.43B, an increase of 61.50%. That is a compound annual growth rate of 3.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 2.43B | -12.62% |
| Dec 31, 2025 | 2.79B | 2.79% |
| Dec 31, 2024 | 2.71B | -16.13% |
| Dec 29, 2023 | 3.23B | -0.89% |
| Dec 30, 2022 | 3.26B | 13.02% |
| Dec 30, 2021 | 2.89B | 3.11% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BRIM Biotechnology | 2.98B |
| Chunghwa Chemical Synthesis & Biotech | 2.98B |
| HeXun Biosciences | 2.85B |
| Apex Biotechnology | 2.83B |
| Syngen Biotech | 2.69B |
| Sunhawk Vision Biotech | 2.61B |
| 3D Global Biotech | 2.39B |
| Sunny Pharmtech | 2.21B |